Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6942-6949

  Sugano, Masahiko ^a   Egilmez, Nejat K ^a   Yokota, Sandra J ^a   Chen, Fang An ^a   Harding, Jennifer ^b   Huang, Shi Kun ^b   Bankert, Richard B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; DOXORUBICIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; MONOCLONAL ANTIBODY;

ADRENAL METASTASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; INTERNALIZATION; LIVER METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; TUMOR XENOGRAFT;

ADRENAL GLAND NEOPLASMS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTEGRINS; LIPOSOMES; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; NEOPLASM TRANSPLANTATION; PROTEIN BINDING; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034671316     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Cancer statistics
2. Large unilamellar liposomes with low uptake into the reticuloendothelial system
3. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
4. Pharmacokinetics and anti-tumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid
5. Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes
6. Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes
7. Sterically stabilized liposomes: Improvements in pharmacokinetics and anti-tumor therapeutic efficacy
8. Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes
9. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts
10. Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes
11. Immunospecific tumor-targeting of drug-containing liposomes
12. Ligand targeting of liposomes
13. Cytotoxicity of antibody-directed liposomes that recognize two receptors on K562 cells
14. Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody
15. Interactions of immunoliposomes with target cells
16. Small liposomes are better than large liposomes for specific drug delivery in vitro
17. Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles
18. Immunospecific targeting of cytosine arabinonucleoside-containing liposomes to the idiotype on the surface of a murine B-cell tumor in vitro and in vivo
19. Monoclonal antibody targeting of liposomes to mouse lung in vivo
20. Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
21. HER2 immunoliposomes for cancer therapy
22. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies
23. Synthesis of end-group functionalized polyethylene glycol-lipid conjugates for preparation of polymer-grafted liposomes
24. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells
25. Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures
26. Hapten-specific, B cell repertoire probed by hybridoma technology: Selection and characterization of representative clonotypes from the antibody-forming cell pool
27. Clones of tumor cells derived from a single primary human lung tumor reveal different patterns of β1 integrin expression
28. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts
29. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs
30. Growth of human tumor xenografts in SCID mice quantified using an immunoassay to measure tumor marker protein in serum
31. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
32. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin-2 receptor β-chain monoclonal antibody in mice
33. X immunoliposomes: Targeting to B16BL6, HRT-18 cancer cells
34. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model
35. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice
36. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma
37. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo
38. Early intervention in cancer using monoclonal antibodies and other biological ligands: Micropharmacology and the "binding site barrier"
39. Microvascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft
40. Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency
41. The scid mutation in mice causes a general defect in DNA repair
42. A link between double-strand break-related repair and V(D)J recombination: The scid mutation
43. Toxicity of free radical forming anticancer agents
44. Increased therapeutic index of doxorubicin in the therapy of non-small cell lung cancer: A prospective, randomized study
45. Adoptive transfer of human lymphoid cells to severely immunodeficient mice: Models for normal human immune function, autoimmunity, lymphomagenesis and AIDS
46. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies
47. Antitumor immune response to human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice
48. Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice
49. Expression of the VLA β1 integrin family in bladder cancer
50. Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule
51. Expression and function of VLA-α2, -α3, -α5, and -α6 integrins receptors in pancreatic carcinoma
52. Role of integrin α2β1 (VLA-2) in the migration of human melanoma cells on laminin and type IV collagen
53. Role of β-1 integrins in organ specific adhesion of melanoma cells in vitro
54. The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation
55. VLA-3 distribution in normal and neoplastic non-lymphoid human tissues
56. Integrin expression in cutaneous malignant melanoma association of the α3/β1 heterodimer with tumor progression